NCT06917261View on ClinicalTrials.gov

Evaluation of the Diagnostic Performance of the TestNPass DM-DIV for SARS-CoV-2 Using a Nasopharyngeal Sample

NANot yet recruitingINTERVENTIONAL

Enrollment

400

Participants

Timeline

Start Date

April 30, 2025

Primary Completion Date

October 30, 2025

Study Completion Date

December 30, 2025

Conditions

SARS-CoV-2 Infection

Interventions

DIAGNOSTIC_TEST

nasopharyngeal swab.

The only additional procedure related to the study is a nasopharyngeal swab.

Trial Locations (2)

38700

University Hospital of Grenoble, emergency department, Grenoble

University Hospital of Grenoble, infectious disease department, Grenoble

All Listed Sponsors

lead

University Hospital, Grenoble

OTHER

NCT06917261 - Evaluation of the Diagnostic Performance of the TestNPass DM-DIV for SARS-CoV-2 Using a Nasopharyngeal Sample | Biotech Hunter | Biotech Hunter